Targeted Cancer Therapy: Class Related Toxicities
Kang, N.; Forcello, N.
Connecticut Medicine 79(2): 109-113
2015
ISSN/ISBN: 0010-6178 PMID: 26244211 Document Number: 684605
Document emailed within 1 workday
Related Documents
Grothey, A. 2006: Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer Oncology 20(14 Suppl 10: 21-28Tu, S.-M.; Lin, S.-H.; Podoloff, D.A.; Logothetis, C.J. 2010: Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer Clinical Advances in Hematology and Oncology: H&o 8(5): 341-351
Tongyoo, A. 2010: Targeted therapy: novel agents against cancer Journal of the Medical Association of Thailand 93(Suppl 7): S311-S323
Rajpal, S.; Venook, A.P. 2006: Targeted therapy in colorectal cancer Clinical Advances in Hematology and Oncology: H&o 4(2): 124-132
Hwang, J.; Marshall, J.L. 2006: Targeted therapy for colorectal cancer Current Opinion in Investigational Drugs 7(12): 1062-1066
Yano, S. 2013: Cancer targeted therapy and resistance signals SEIKAGAKU. Journal of Japanese Biochemical Society 85(6): 475-483
Nonomura, N.; Nakayama, M.; Takayama, H.; Nishimura, K.; Okuyama, A. 2008: Molecular-targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 63-66
Hashimoto, Y.; Naruyama, H.; Ando, R.; Okada, S.; Tozawa, K.; Kohri, K. 2008: Molecular targeted therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 54(1): 57-61
Henderson, I.C. 2012: Targeted therapy: a sea change in the treatment of cancer Oncology 26(11): 1035; 1039
Wcisło, G. 2008: Molecular underpinnings of the targeted therapy for cancer Acta Poloniae Pharmaceutica 65(6): 633-640
Ikeda, S. 2013: Economic evaluation of targeted cancer therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 967-970
Klener, P.; Klener, P. 2012: Molecularly-targeted and biological anti-cancer therapy Folia Biologica 58(1): 1-6
Jerzak, K.J.; Raphael, J.; Desautels, D.N.; Blanchette, P.S.; Tyono, I.; Pritchard, K.I. 2018: Bone-Targeted Therapy in Early Breast Cancer Oncology 32(11): 562-569
Herbst, R.S. 2002: Targeted therapy in non-small-cell lung cancer Oncology 16(9 Suppl 9: 19-24
Lea, P.; Ling, M. 2008: New molecular assays for cancer diagnosis and targeted therapy Current Opinion in Molecular Therapeutics 10(3): 251-259
Ristimäki, A.; Kytölä, S.; Haglund, C.; Bono, P. 2013: Targeted therapy of a cancer patient is multiprofessional collaboration Duodecim; Laaketieteellinen Aikakauskirja 129(10): 1071-1079
Shimizu, K.; Mimura, T.; Harada, T.; Tanaka, S. 1994: Current status and prospects for targeted therapy for thyroid cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 743-748
Nakamura, Y.; Yamamoto, N. 2009: Second-line treatment and targeted therapy of advanced lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 710-716
Shi, Y.; Sun, Y. 2014: The development trend of targeted therapy in non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 36(7): 481-484
Deshpande, H.A.; Gettinger, S.N.; Sosa, J.A. 2010: Targeted therapy for thyroid cancer: An updated review of investigational agents Current Opinion in Investigational Drugs 11(6): 661-668